Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Currency
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Krishnan Mahesh Insider Profile
4 Followers
Krishnan Mahesh, Director at Chinook Therapeutics, holds 0.00 shares in Chinook Therapeutics (Ticker: KDNY).
Krishnan Mahesh Chinook Therapeutics (KDNY)Director
Chinook Therapeutics (KDNY)
Director
Not Ranked
Krishnan Mahesh has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Krishnan Mahesh does not currently own shares as a corporate insider.
A breakdown of Krishnan Mahesh's holdings
Insider Roles
Krishnan Mahesh does not currently hold a role as a corporate insider.
Roles that Krishnan Mahesh holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Krishnan Mahesh
Krishnan Mahesh's Trading History
List of latest transactions for each holding click on a transaction to see Krishnan Mahesh's performance on stock
You May Also Like
Krishnan Mahesh insider profile FAQ
What is the percentage of profitable transactions made by Krishnan Mahesh?
The percentage of profitable transactions made by Krishnan Mahesh is ―.
What is the average return per transaction made by Krishnan Mahesh?
The average return per transaction made by Krishnan Mahesh is ―.
What stocks does Krishnan Mahesh hold?
Krishnan Mahesh holds: KDNY stocks.
What was Krishnan Mahesh’s latest transaction?
Krishnan Mahesh latest transaction was an Uninformative Sell of ―.
What was Krishnan Mahesh's most profitable transaction?
Krishnan Mahesh’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Krishnan Mahesh's role in Chinook Therapeutics?
Krishnan Mahesh's role in Chinook Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.